FGEN logo

FGEN

FibroGen Inc

$12.23
+$0.92(+8.13%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$46.55M
Volume
39.99K
52W Range
$4.50 - $21.95
Target Price
$43.00
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$180.8M$179.6M$131.0M$213.0M$256.6M$176.3M$235.3M$140.7M$46.8M$29.6M
Total Revenue
$180.8M$183.2M$131.0M$213.0M$256.6M$176.3M$235.3M$140.7M$46.8M$29.6M
COST OF GOODS SOLD
Cost of Revenue
----------$8.9M$12.9M$20.3M$4.0M$15.6M
GROSS PROFIT
Gross Profit
$180.8M$179.6M$131.0M$213.0M$256.6M$167.4M$222.4M$120.5M$42.8M$14.1M
OPERATING EXPENSES
Operating Expenses
$-258.5M$-233.2M$-248.3M$-299.7M$345.9M$368.2M$523.8M$421.5M$353.0M$145.0M
Research & Development
$214.1M$187.2M$196.5M$235.8M$209.3M$252.9M$387.0M$296.8M$266.5M$95.7M
Research Expense
$214.1M$187.2M$196.5M$235.8M$209.3M$252.9M$387.0M$296.8M$266.5M$95.7M
Selling, General & Administrative
$44.4M$46.0M$51.8M$63.8M$135.5M$106.4M$136.8M$124.7M$86.5M$49.3M
Selling & Marketing Expenses
------$63.8M----$12.9M$20.3M----
General & Administrative Expenses
$44.4M$46.0M$51.8M$63.8M$135.5M$106.4M$136.8M$124.7M$86.5M$49.3M
Salaries & Wages
$-27.7M$-32.1M$-37.5M$-52.1M--$8.9M----$50.8M$25.2M
Depreciation & Amortization
$-5.7M$-6.0M$-6.1M$-6.6M$11.1M$11.7M$10.2M$10.0M$9.5M$2.7M
Depreciation & Amortization
$-5.7M$-6.0M$-6.1M$-6.6M$11.1M$11.7M$10.2M$10.0M$9.5M$2.7M
Amortization
--------$10.3M$10.4M$4.6M$587.0K$412.0K--
Securities Amortization
--------------$20.3M----
Other Operating Expenses
--------$-1.1M$12.3M$14.7M$17.1M$15.2M--
OPERATING INCOME
Operating income
$-77.6M$-53.7M$-117.3M$-86.7M$-89.3M$-191.9M$-288.5M$-301.0M$-322.7M$-150.4M
EBITDA
$-65.8M$-42.3M$-102.9M$-68.6M$-56.0M$-164.3M$-273.7M$-282.8M$-305.2M$-142.5M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$11.0M$10.7M$9.7M$11.0M$2.9M$2.4M$2.2M$1.4M$8.1M$8.2M
Intinc
$3.1M$2.6M$6.4M$11.6M$15.5M$5.6M--------
Net Non-Operating Interest Income/Expense
$-7.9M$-8.1M$-3.3M$577.0K$12.7M$-2.4M$-1.1M$-6.2M$-8.1M$-8.2M
Other Income/Expense
----------$-5.4M$71.0K$-9.2M$-7.6M$-5.3M
Other Special Charges
----------$5.6M$-1.1M$7.6M$7.6M$5.3M
SPECIAL ITEMS
Restructring And Mn A Income
----------------$12.6M$19.5M
Special Income Charges
----------------$-12.6M$-19.5M
PRE-TAX INCOME
EBIT
$-74.5M$-51.0M$-110.8M$-75.1M$-73.8M$-186.3M$-288.5M$-293.4M$-315.1M$-145.1M
Pre-Tax Income
$-85.5M$-61.8M$-120.6M$-86.1M$-76.6M$-188.7M$-290.7M$-294.9M$-323.2M$-153.4M
INCOME TAX
Tax Provision
$242.0K$-71.0K$321.0K$304.0K$328.0K$360.0K$347.0K$358.0K$-252.0K$-269.0K
NET INCOME
Net Income
$-85.8M$-61.7M$-120.9M$-86.4M$-77.0M$-189.3M$-290.0M$-293.7M$-284.2M$-47.6M
Net Income (Continuing Operations)
$-85.8M$-61.7M$-120.9M$-86.4M$-77.0M$-189.3M$-290.0M$-293.7M$-323.0M$-153.1M
Net Income (Discontinued Operations)
$-85.8M$-61.7M$-120.9M$-86.4M$-77.0M$-189.3M$-290.0M$-293.7M$-284.2M$-47.6M
Net Income (Common Stockholders)
$-85.8M$-61.7M$-120.9M$-86.4M$-74.7M$-189.3M$-290.0M$-293.7M$-284.2M$-47.6M
Normalized Income
------------------$-135.9M
TOTALS
Total Expenses
$-258.5M$-233.2M$-248.3M$-299.7M$345.9M$377.1M$536.7M$441.8M$356.9M$160.6M
SHARE & EPS DATA
Average Shares Outstanding
$2.4M$2.5M$2.9M$3.4M$3.5M$3.6M$3.7M$3.7M$3.9M$100.0M
Average Shares Outstanding (Diluted)
$2.4M$2.5M$2.9M$3.4M$3.5M$3.6M$3.7M$3.7M$3.9M$100.0M
Shares Outstanding
$2.5M$2.6M$3.3M$3.4M$3.5M$3.7M$3.7M$3.8M$4.0M$100.9M
Basic EPS
--------$-22.25$-52.75$-78.5$-78.5$-73$-0.48
Basic EPS (Continuing Operations)
--------$-22.25$-52.75$-78.5$-78.5$-73$-1.53
Diluted EPS
$-35.5$-24.5$-43.25$-25.75$-22.25$-52.75$-78.5$-78.5$-73$-0.48
Diluted EPS (Continuing Operations)
--------------$-78.5$-73$-1.53
OTHER METRICS
Basic Discontinuous Operations
------------------$1.05
Diluted Discontinuous Operations
------------------$1.05
Earnings from equity interest
----------$-202.0K$1.0M$1.6M$2.6M--
Earnings From Equity Interest Net Of Tax
----------$-202.0K$1.0M$1.6M$2.6M--
Gain On Sale Of P P E
------------------$1.7M
Marketing Expense
--------------$20.3M----
Minority Interests
--------$535.4M$441.4M--------
Net Income Discontinuous Operations
----------------$38.7M$105.5M
Other Gain Loss From Disposition Of Discontinued Operations
----------------$38.7M$105.5M
Other Gand A
$44.4M$46.0M$51.8M$63.8M$135.5M$106.4M$136.8M$124.7M$86.5M$49.3M
Rent And Landing Fees
$44.4M$46.0M$51.8M$63.8M------------
Selling Expense
------$63.8M----$12.9M------
Restruct
----------------$12.6M$19.5M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2FGEN$12.23+8.1%39.99K
3
4
5
6

Get FibroGen Inc Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.